John Y. Televantos - 13 Feb 2023 Form 4 Insider Report for BALCHEM CORP (BCPC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
15 Feb 2023, 15:15:58 UTC
Prior SEC filing
10 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Travis Larsen, Attorney in Fact for John Y. Televantos

Key filing fact

John Y. Televantos filed Form 4 for BALCHEM CORP (BCPC) on 15 Feb 2023.

Key facts

  • This page summarizes John Y. Televantos's Form 4 filing for BALCHEM CORP (BCPC).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 15 Feb 2023, 15:15.

Change

  • Previous filing in this sequence was filed on 10 Feb 2023.
  • Current net transaction value: -$35,003.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BCPC transaction

Common Stock

Tax liability

Transaction value
$35,003
Shares
-258
Change %
-0.88%
Price
$135.67
Shares after
29,078
Date
13 Feb 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/13/2020).

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .